Regulation of hindbrain Pyy expression by acute food deprivation, prolonged caloric restriction, and weight loss surgery in mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 303, Issue 5, 2012, Pages

  Gelegen, C ^a   Chandarana, K ^a   Choudhury, A I ^b   Al Qassab, H ^a   Evans, I M ^c   Irvine, E E ^a   Hyde, C B ^d   Claret, M ^e   Andreelli, F ^f,g   Sloan, S E ^h   Leiter, A B ^h   Withers, D J ^b   Batterham, R L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Rayne Institute ^*  (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^f INSTITUT COCHIN   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Brain stem; Energy homeostasis; Fasting; Peptide YY; Satiety

Indexed keywords

ISOPROTEIN; LEPTIN; MESSENGER RNA; PEPTIDE YY [3-36];

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPETITE; ARTICLE; BARIATRIC SURGERY; BRAIN STEM; CALORIC RESTRICTION; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; FOOD DEPRIVATION; GIGANTOCELLULAR RETICULAR NUCLEUS; HYPOGLOSSAL NUCLEUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MESENCEPHALON; MOUSE; NONHUMAN; NUTRITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RHOMBENCEPHALON;

ANIMALS; BARIATRIC SURGERY; BRAIN STEM; CALORIC RESTRICTION; FOOD DEPRIVATION; GENE EXPRESSION REGULATION; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURONS; OBESITY; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; PEPTIDE YY; RANDOM ALLOCATION; RHOMBENCEPHALON; RNA, MESSENGER;

EID: 84865712162     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00033.2012     Document Type: Article

References (67)

1. Abbott CR, Small CJ, Kennedy AR, Neary NM, Sajedi A, Ghatei MA, Bloom SR. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res 1043: 139-144, 2005.
2. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89: 1070-1077, 1985.
3. Athanassiadis T, Olsson KA, Kolta A, Westberg KG. Identification of c-Fos immunoreactive brainstem neurons activated during fictive mastication in the rabbit. Exp Brain Res 165: 478-489, 2005.
4. Banks WA, Coon AB, Robinson SM, Moinuddin A, Shultz JM, Nakaoke R, Morley JE. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 53: 1253-1260, 2004.
5. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349: 941-948, 2003.
6. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418: 650-654, 2002.
7. Batterham RL, ffytche DH, Rosenthal JM, Zelaya FO, Barker GJ, Withers DJ, Williams SC. PYY modulation of cortical, hypothalamic brain areas predicts feeding behaviour in humans. Nature 450: 106-109, 2007.
8. Batterham RL, Heffron H, Kapoor S, Chivers JE, Chandarana K, Herzog H, Le Roux CW, Thomas EL, Bell JD, Withers DJ. Critical role for peptide YY in protein-mediated satiation, body-weight regulation. Cell Metab 4: 223-233, 2006.
9. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med 60: 355-366, 2009.
10. Berrettini WH, Kaye WH, Gwirtsman H, Allbright A. Cerebrospinalfluid peptide YY immunoreactivity in eating disorders. Neuropsychobiology 19: 121-124, 1988.
11. Berthoud HR, Sutton GA, Townsend RL, Patterson LM, Zheng HY. Brainstem mechanisms integrating gut-derived satiety signals and descending forebrain information in the control of meal size. Physiol Behav 89: 517-524, 2006.
12. Blomqvist AG, Herzog H. Y-receptor subtypes-how many more? Trends Neurosci 20: 294-298, 1997.
13. Braz JM, Basbaum AI. Genetically expressed transneuronal tracer reveals direct and indirect serotonergic descending control circuits. J Comp Neurol 507: 1990-2003, 2008.
14. Brodin L, Rawitch A, Taylor T, Ohta Y, Ring H, Hokfelt T, Grillner S, Terenius L. Multiple forms of pancreatic polypeptide-related compounds in the lamprey CNS: partial characterization and immunohistochemical localization in the brain stem and spinal cord. J Neurosci 9: 3428-3442, 1989.
15. Cabrele C, Beck-Sickinger AG. Molecular characterization of the ligandreceptor interaction of the neuropeptide Y family. J Pept Sci 6: 97-122, 2000.
16. Chandarana K, Gelegen C, Karra E, Choudhury AI, Drew ME, Fauveau V, Viollet B, reelli F, Withers DJ, Batterham RL. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes 60: 810-818, 2011.
17. Chelikani PK, Haver AC, Reidelberger RD. Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 287: R1064-R1070, 2004.
18. Choudhury AI, Heffron H, Smith MA, Al-Qassab H, Xu AW, Selman C, Simmgen M, Clements M, Claret M, Maccoll G, Bedford DC, Hisadome K, Diakonov I, Moosajee V, Bell JD, Speakman JR, Batterham RL, Barsh GS, Ashford ML, Withers DJ. The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest 115: 940-950, 2005.
19. Corp ES, McQuade J, Krasnicki S, Conze DB. Feeding after fourth ventricular administration of neuropeptide Y receptor agonists in rats. Peptides 22: 493-499, 2001.
20. Dumont Y, Moyse E, Fournier A, Quirion R. Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema. J Mol Neurosci 33: 294-304, 2007.
21. Ekman R, Wahlestedt C, Bottcher G, Sundler F, Hakanson R, Panula P. Peptide YY-like immunoreactivity in the central nervous system of the rat. Regul Pept 16: 157-168, 1986.
22. Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381: 415-421, 1996.
23. Evans S, Pamuklar Z, Rosko J, Mahaney P, Jiang N, Park C, Torquati A. Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction. Surg Endosc 2011.
24. Franklin KBJ, Paxinos GM. The Mouse Brain in Stereotaxic Coordinates. New York: Academic, 1997.
25. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL. A receptor subtype involved in neuropeptide-Yinduced food intake. Nature 382: 168-171, 1996.
26. Gestreau C, Dutschmann M, Obled S, Bianchi AL. Activation of XII motoneurons and premotor neurons during various oropharyngeal behaviors. Respir Physiol Neurobiol 147: 159-176, 2005.
27. Glavas MM, Grayson BE, Allen SE, Copp DR, Smith MS, Cowley MA, Grove KL. Characterization of brainstem peptide YY (PYY) neurons. J Comp Neurol 506: 194-210, 2008.
28. Grill HJ, Hayes MR. The nucleus tractus solitarius: a portal for visceral afferent signal processing, energy status assessment and integration of their combined effects on food intake. Int J Obes (Lond) 33, Suppl 1: S11-S15, 2009.
29. Hagan MM. Peptide YY: a key mediator of orexigenic behavior. Peptides 23: 377-382, 2002.
30. Hashimoto N, Katayama T, Ishiwata Y, Nakamura Y. Induction of rhythmic jaw movements by stimulation of the mesencephalic reticular formation in the guinea pig. J Neurosci 9: 2887-2901, 1989.
31. Kanatani A, Mashiko S, Murai N, Sugimoto N, Ito J, Fukuroda T, Fukami T, Morin N, Macneil DJ, Van der Ploeg LH, Saga Y, Nishimura S, Ihara M. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptordeficient, and Y5 receptor-deficient mice. Endocrinology 141: 1011-1016, 2000.
32. Karra E, Batterham RL. The role of gut hormones in the regulation of body wt and energy homeostasis. Mol Cell Endocrinol 316: 120-128, 2010.
33. Karra E, Chandarana K, Batterham RL. The role of peptide YY in appetite regulation and obesity. J Physiol 587: 19-25, 2009.
34. Kastin AJ, Akerstrom V. Fasting, but not adrenalectomy, reduces transport of leptin into the brain. Peptides 21: 679-682, 2000.
35. Kastin AJ, Pan W. Dynamic regulation of leptin entry into brain by the blood-brain barrier. Regul Pept 92: 37-43, 2000.
36. Kaye WH, Berrettini W, Gwirtsman H, George DT. Altered cerebrospinal- fluid neuropeptide-y, peptide-Yy immunoreactivity in anorexia and bulimia-nervosa. Arch Gen Psychiatry 47: 548-556, 1990.
37. Keire DA, Mannon P, Kobayashi M, Walsh JH, Solomon TE, Reeve JR Jr. Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am J Physiol Gastrointest Liver Physiol 279: G126-G131, 2000.
38. Lambeir AM, Durinx C, Scharpe S, De Meester I. Dipeptidyi-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Labor Sci 40: 209-294, 2003.
39. Lawson EA, Eddy KT, Donoho D, Misra M, Miller KK, Meenaghan E, Lydecker J, Herzog D, Klibanski A. Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index. Eur J Endocrinol 164: 253-261, 2011.
40. Le Roux CW, Batterham RL, Aylwin SJB, Patterson M, Borg CM, Wynne KJ, Kent A, Vincent RP, Gardiner J, Ghatei MA, Bloom SR. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147: 3-8, 2006.
41. Mashiko S, Moriya R, Ishihara A, Gomori A, Matsushita H, Egashira S, Iwaasa H, Takahashi T, Haga Y, Fukami T, Kanatani A. Synergistic interaction between neuropeptide Y-1 and Y-5 receptor pathways in regulation of energy homeostasis. Eur J Pharmacol 615: 113-117, 2009.
42. Mentlein R, Dahms P, Grandt D, Kruger R. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul Pept 49: 133-144, 1993.
43. Mentzel S, Dijkman HBPM, Vanson JPHF, Koene RAP, Assmann KJM. Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice. J Histochem Cytochem 44: 445-461, 1996.
44. Misra M, Miller KK, Tsai P, Gallagher K, Lin A, Lee N, Herzog DB, Klibanski A. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 91: 1027-1033, 2006.
45. Mitro A, Lojda Z. Histochemistry of proteases in ependyma, choroidplexus and leptomeninges. Histochemistry 88: 645-646, 1988.
46. Mullins DE, Guzzi M, Xia L, Parker EM. Pharmacological characterization of the cloned neuropeptide Y y(6) receptor. Eur J Pharmacol 395: 87-93, 2000.
47. Munsch S, Biedert E, Meyer AH, Herpertz S, Beglinger C. CCK, ghrelin, and PYY responses in individuals with binge eating disorder before and after a cognitive behavioral treatment (CBT). Physiol Behav 97: 14-20, 2009.
48. Neary MT, Batterham RL. Gut hormones: implications for the treatment of obesity. Pharmacol Ther 124: 44-56, 2009.
49. Pieribone VA, Brodin L, Friberg K, Dahlstrand J, Soderberg C, Larhammar D, Hokfelt T. Differential expression of mRNAs for neuropeptide Y-related peptides in rat nervous tissues: possible evolutionary conservation. J Neurosci 12: 3361-3371, 1992.
50. Rahardjo GL, Huang XF, Tan YY, Deng C. Decreased plasma peptide YY accompanied by elevated peptide YY and Y2 receptor binding densities in the medulla oblongata of diet-induced obese mice. Endocrinology 148: 4704-4710, 2007.
51. Raposinho PD, Pierroz DD, Broqua P, White RB, Pedrazzini T, Aubert ML. Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism. Mol Cell Endocrinol 185: 195-204, 2001.
52. Schonhoff S, Baggio L, Ratineau C, Ray SK, Lindner J, Magnuson MA, Drucker DJ, Leiter AB. Energy homeostasis and gastrointestinal endocrine differentiation do not require the anorectic hormone peptide YY. Mol Cell Biol 25: 4189-4199, 2005.
53. Schwartz GJ. Brainstem integrative function in the central nervous system control of food intake. Front Eating Weight Regul 63: 141-151, 2010.
54. Scott MM, Lachey JL, Sternson SM, Lee CE, Elias CF, Friedman JM, Elmquist JK. Leptin targets in the mouse brain. J Comp Neurol 514: 518-532, 2009.
55. Selman C, Kerrison ND, Cooray A, Piper MD, Lingard SJ, Barton RH, Schuster EF, Blanc E, Gems D, Nicholson JK, Thornton JM, Partridge L, Withers DJ. Coordinated multitissue transcriptional and plasma metabonomic profiles following acute caloric restriction in mice. Physiol Genomics 27: 187-200, 2006.
56. Soderberg C, Pieribone VA, Dahlstrand J, Brodin L, Larhammar D. Neuropeptide role of both peptide YY and neuropeptide-Y in vertebrates suggested by abundant expression of their messenger-RNAs in a cyclostome brain. J Neurosci Res 37: 633-640, 1994.
57. Solano JM, Jacobson L. Glucocorticoids reverse leptin effects on food intake, body fat in mice without increasing NPY mRNA. Am J Physiol Endocrinol Metab 277: E708-E716, 1999.
58. Stremel RW, Waldrop TG, Richard CA, Iwamoto GA. Cardiorespiratory responses to stimulation of the nucleus reticularis gigantocellularis. Brain Res Bull 24: 1-6, 1990.
59. Tork I. Anatomy of the serotonergic system. Ann NY Acad Sci 600: 9-34, 1990.
60. Troy S, Soty M, Ribeiro L, Laval L, Migrenne S, Fioramonti X, Pillot B, Fauveau V, Aubert R, Viollet B, Foretz M, Leclerc J, Duchampt A, Zitoun C, Thorens B, Magnan C, Mithieux G, reelli F. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 8: 201-211, 2008.
61. Tseng LLF, Tang R, Stackman R, Camara A, Fujimoto JM. Brainstem sites differentially sensitive to beta-endorphin and morphine for analgesia and release of met-enkephalin in anesthetized rats. J Pharmacol Exper Therapeut 253: 930-937, 1990.
62. Ukkola OH, Puurunen VP, Piira OP, Niva JT, Lepojarvi ES, Tulppo MP, Huikuri HV. High serum fasting peptide YY (3-36) is associated with obesity-associated insulin resistance and type 2 diabetes. Regul Pept 170: 38-42, 2011.
63. Unniappan S, McIntosh CH, Demuth HU, Heiser U, Wolf R, Kieffer TJ. Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY. Diabetologia 49: 1915-1923, 2006.
64. Urban MO, Smith DJ. Nuclei within the rostral ventromedial medulla mediating morphine antinociception from the periaqueductal gray. Brain Res 652: 9-16, 1994.
65. VanderHorst VGJM, Ulfhake B. The organization of the brainstem, spinal cord of the mouse: relationships between monoaminergic, cholinergic, and spinal projection systems. J Chem Neuroanat 31: 2-36, 2006.
66. Williams KW, Zsombok A, Smith BN. Rapid inhibition of neurons in the dorsal motor nucleus of the vagus by leptin. Endocrinology 148: 1868-1881, 2007.
67. Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes 46: 717-719, 1997.